ACTA1 and ovarian carcinoma: Indeed, ADSCs from the momentum of ovarian cancer patients, whether they had metastases or not, were found to express higher levels of α-smooth muscle actin (α-SMA) than ADSCs from patients with benign gynecologic disease [43].